UCSF to Study Alzheimer’s Genetics in North American Asians
UCSF is helping to create the first large group of Asian American study participants to help improve Alzheimer’s disease care for the Asian community North America.
University of California San Francisco
Give to UCSFUCSF is helping to create the first large group of Asian American study participants to help improve Alzheimer’s disease care for the Asian community North America.
UCSF researchers tested nitroglycerin patches, an treatment for chest pain from coronary artery disease, for menopausal hot flashes. Short-term benefits were seen, but not long-term as some side effects occurred.
Exposure to trichloroethylene (TCE), a chemical found in the air, water, and soil, may increase the risk of Parkinson's disease by 70%, according to a UCSF study. TCE is commonly used today as a degreasing solvent.
Saul Villeda, the 2023 recipient of the Byers Award, delivered a lecture titled "Blood Work and the Brain: Deciphering the Language of Cognitive Rejuvenation." His research focuses on understanding the biological mechanisms behind cognitive decline with age and exploring potential ways to reverse it.
What is “social prescribing” and what is UCSF doing to promote it? UCSF experts address the health ramifications of social isolation.
Emily Goldberg's lab studies what happens during aging to a particular set of immune cells: those embedded in fat tissue. She hypothesizes that changes to these cells during aging could be key to age-related inflammation.
Leanne Jones, PhD, is at the forefront of studying how stem cells are influenced by their surrounding environment and directed to differentiate into one type of cell or another – research that’s critical for stem cell therapies to be successful.
Sleep medications may increase risk of dementia for white people, though the type and amount of medication may also explain the higher probability.
Sociologist Stacy Torres, PhD, studied a group of older adults that hung out at a Manhattan bakery. She reflects on what they taught her about survival and belonging.
UCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.
UCSF Experts Present Research at the Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Francisco.
Risk of death or hospitalization from COVID-19 were found to be greater for patients with PTSD.
A $147 million grant will expand diversity among Alzheimer’s disease research participants, and involve partners from UCSF, the San Francisco VA Medical Center, and the Northern California Institute for Research and Education.
Not all senescent cells are harmful “zombies” that should be wiped out to prevent age-related disease. New research from UCSF found that some of them are embedded in young, healthy tissues and promote normal repair from damage.
A new study points to another persistent effect of COVID-19, identified months after infection: reduced exercise capacity.
After a decade of work, scientists at UCSF’s Neuroscape Center have developed a suite of video game interventions that improve key aspects of cognition in aging adults.
A new study shows that fewer Black, Hispanic and Asian patients would qualify for these treatments that may slow Alzheimer’s progression, since cognitive impairment in these groups is more likely to be caused by other forms of dementia that may be unrelated to amyloid plaques.
UCSF researchers Adam Staffaroni, PhD, and Adam Boxer, MD, PhD developed models of clinical and biomarker dynamics to determine the temporal sequence of biomarker and clinical changes in f-FTD before disease progression begins.
The study, funded by the National Institute on Aging, recruited people who were 50 and older and homeless, and followed them for a median of 4.5 years. By interviewing people every six months about their health and housing status, researchers were able to examine how things like regaining housing, using drugs, and having various chronic conditions, such as diabetes, affected their risk of dying.
Most people are at risk for periodic loneliness, but for midlife and older adults who identify as Hispanic/Latinx, or who live in poverty, loneliness may be less likely to resolve over time.
According to a new UCSF study, screening for depression at the primary care level could dramatically increase the likelihood of treatment for those who are traditionally undertreated — racial and ethnic minority individuals, older adults, those with limited English proficiency and men.
UCSF Medical Center has been ranked among the country’s finest hospitals in adult care by U.S. News & World Report’s prestigious Best Hospitals survey.